Main public logs
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 14:45, 13 April 2024 Fire talk contribs created page Lumisterol/ja (Created page with "ルミステロール") Tags: Mobile edit Mobile web edit
- 14:45, 13 April 2024 Fire talk contribs created page Translations:Lumisterol/Page display title/ja (Created page with "ルミステロール")
- 14:45, 13 April 2024 Fire talk contribs marked Lumisterol for translation
- 14:45, 13 April 2024 Fire talk contribs set the priority languages for translatable page Lumisterol to Japanese
- 14:42, 13 April 2024 Fire talk contribs created page lumisterol (Q22026) (wbeditentity-create:2|en: lumisterol, chemical compound)
- 14:42, 13 April 2024 Fire talk contribs created page Lumisterol (Created page with "<languages /> <translate> {{chembox | Watchedfields = changed | verifiedrevid = 408754551 | Name = Lumisterol | ImageFile = Lumisterol.svg | ImageSize = 200px | ImageName = Lumisterol | IUPACName = (22''E'')-9β,10α-Ergosta-5,7,22-trien-3β-ol | SystematicName = (1''R'',3a''R'',7''S'',9a''S'',9b''R'',11a''R'')-1-[(2''R'',3''E'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-9a,11a-dimethyl-2,3,3a,6,7,8,9,9a,9b,10,11,11a-dodecahydro-1''H''-cyclopenta[''a'']phenanthren-7-ol |Sectio...")
- 14:38, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/14/ja (Created page with "過剰摂取の後期症状には以下が含まれる： {{div col|colwidth=18em}} * 食欲不振 * 体重減少 * 結膜炎（石灰沈着性） * 膵炎 * 羞明 * 鼻出血 * そう痒症 * 高体温症 * 性欲減退 * ＊BUN上昇 * 高コレステロール血症 * ASTおよびALTの上昇 * 異所性石灰化 * 高血圧 * 心不整脈 * 傾眠 * 死亡 * 精神病（まれ） {{div col end}}")
- 14:36, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/13/ja (Created page with "過剰摂取の初期症状には以下のようなものがある： {{div col|colwidth=18em}} * 衰弱 * 頭痛 * 傾眠 * 吐き気 * 嘔吐 * 口の渇き * 便秘 * 筋肉痛 * 骨の痛み * 口の中の金属味。 {{div col end}} しかし、これらの症状の中には腎不全を示すものもあり、それゆえに患者の状態によってマスクされることがあることは注目に値する。")
- 14:36, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/12/ja (Created page with "==過剰投与{{Anchor|Overdose}}== 電解質異常（例えば、高カルシウム血症および高リン血症）は、一般的な過量投与症状である。治療はほとんどが支持療法であり、特に電解質異常を是正し、サプリメントおよび食事の両形態でカルシウムの摂取量を減らすことに注意を払う。カルシウムは血漿蛋白質との結合が強いため、[...")
- 14:35, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/11/ja (Created page with "==相互作用{{Anchor|Interactions}}== パリカルシトールと相互作用する可能性のある薬物は以下の通りである： {{div col|colwidth=30em}} * ケトコナゾール, 肝臓でのパリカルシトールの代謝を阻害することがある。 * ジギトキシン、何らかの原因による高カルシウム血症はジギトキシンの毒性を悪化させることがある。 * Thiazide/ja|チアジ...")
- 14:32, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/10/ja (Created page with "一方、注意事項は以下の通りである： * 肝機能障害 * また、医師は患者のカルシウムとリンの値を定期的にモニターすることが勧められる。")
- 14:32, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/9/ja (Created page with "==禁忌{{Anchor|Contraindications}}== 禁忌は以下の通りである： * ビタミンD中毒 * 高カルシウム血症 * パリカルシトールまたはその賦形剤に対する過敏症")
- 14:31, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/8/ja (Created page with "<sup>‡</sup>これらはグレード3または4の慢性腎臓病の患者にのみみられる副作用である。 <sup>†</sup>これらはグレード5の慢性腎臓病患者にのみみられる副作用である。")
- 14:31, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/7/ja (Created page with "'''一般的でない（頻度0.1～1％）:''' {{div col|colwidth=18em}} * 肝酵素異常<sup>‡</sup> * 便秘<sup>‡</sup> * 口の渇き<sup>‡</sup> * かゆみ<sup>‡</sup> * じんましん * 過敏症<sup>‡</sup> * 筋痙攣<sup>‡</sup> * 出血時間延長 * アスパラギン酸アミノトランスフェラーゼ増加 * 臨床検査異常 * 体重減少 * 血中クレアチニン上昇 * 心停止 * 不整脈 * 心房...")
- 14:17, 13 April 2024 Fire talk contribs created page Translations:Paricalcitol/6/ja (Created page with "'''一般的（頻度1～10％）:''' {{div col|colwidth=18em}} * 下痢<sup>†</sup> * 浮腫 * アレルギー反応 * 関節炎 * めまい<sup>†</sup> * 胃の不快感<sup>†</sup> * [[Gastroesophageal reflux disease/ja|胃食道逆流症<sup>†</sup> * ニキビ<sup>†</sup> * 高カルシウム血症<sup>†</sup> * 低カルシウム血症<sup>†</sup> * Hyperphosp...")
- 23:19, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/5/ja (Created page with "==副作用{{Anchor|Adverse effects}}== '''頻度別の副作用：'''<br /> '''非常に多い（頻度10％以上）:''' * 吐き気")
- 23:18, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/4/ja (Created page with "==医薬用途{{Anchor|Medical uses}}== 医療における主な用途は、慢性腎臓病に伴う二次性副甲状腺機能亢進症の治療である。しかし、現在のところ、この適応症に対する非選択的ビタミンD誘導体に対するパリカルシトールの優位性を示す証拠は十分ではない。")
- 23:18, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/15/ja (Created page with "==作用機序{{Anchor|Mechanism of action}}== thumb|left|パリカルシトールの3次元構造{{clear left}} 1,25-ジヒドロキシエルゴカルシフェロールと同様に、パリカルシトールはビタミンD受容体でアゴニストとして作用し、それによって血中の副甲状腺ホルモン濃度を低下させる。")
- 23:17, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/16/ja (Created page with "==薬物動態{{Anchor|Pharmacokinetics}}== パリカルシトールの血漿中濃度は、初回静脈内投与後2時間以内に急速に対数直線的に減少する。したがって、パリカルシトールの投与頻度は通常1日おき（週3回）以下であるため、複数回の投与による蓄積は期待できない。")
- 23:16, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/17/ja (Created page with "{{Vitamins/ja}} {{Calcium homeostasis/ja}} {{Vitamin D receptor modulators/ja}}")
- 23:16, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/18/ja (Created page with "Category:Secosteroids Category:Vitamin D Category:Drugs developed by AbbVie")
- 23:16, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/3/ja (Created page with "<!-- Society and culture --> 1989年に特許を取得し、1998年に医療用として承認された。")
- 23:16, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/2/ja (Created page with "'''パリカルシトール'''（化学的には'''19-ノル-1,25-(OH)<sub>2</sub>-ビタミンD<sub>2</sub>'''である。Abbott Laboratoriesから'''ゼンプラール'''の商品名で販売されている）は、慢性腎不全に伴う二次性副甲状腺機能亢進症（副甲状腺ホルモンの過剰分泌）の予防と治療に用いられるpharmaceutical dr...")
- 23:14, 12 April 2024 Fire talk contribs created page Paricalcitol/ja (Created page with "パリカルシトール")
- 23:14, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/1/ja (Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 445909355 | IUPAC_name = (1''R'',3''R'',7''E'',17β)-17-[(1''R'',2''E'',4''S'')-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol | image = Paricalcitol.svg | width = 200px | image2 = Paricalcitol3Dan.gif | width2 = 200px <!--Clinical data--> | tradename = Zemplar | Drugs.com = {{drugs.com|monograph|paricalcitol}} | MedlinePlus = a682335 | pregnancy_AU = C | pregnanc...")
- 23:14, 12 April 2024 Fire talk contribs created page Translations:Paricalcitol/Page display title/ja (Created page with "パリカルシトール")
- 23:14, 12 April 2024 Fire talk contribs marked Paricalcitol for translation
- 23:14, 12 April 2024 Fire talk contribs set the priority languages for translatable page Paricalcitol to Japanese
- 23:10, 12 April 2024 Fire talk contribs created page paricalcitol (Q22025) (wbeditentity-create:2|en: paricalcitol, chemical compound)
- 23:09, 12 April 2024 Fire talk contribs created page Template:Clear left (Created page with "{{Clear|left}}<noinclude> {{Documentation|Template:Clear/doc}} </noinclude>")
- 23:08, 12 April 2024 Fire talk contribs created page Paricalcitol (Created page with "{{short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 445909355 | IUPAC_name = (1''R'',3''R'',7''E'',17β)-17-[(1''R'',2''E'',4''S'')-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol | image = Paricalcitol.svg | width = 200px | image2 = Paricalcitol3Dan.gif | width2 = 200px <!--Clinical data--> | tradename = Zemplar | Drugs.com = {{drugs.com|monograph|paricalcitol}} | MedlinePlus...")
- 23:05, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/12/ja (Created page with "Category:Secosteroids Category:Vitamin D {{Vitamins}}")
- 23:04, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/11/ja (Created page with "{{Antipsoriatics/ja}} {{Vitamin D receptor modulators/ja}}")
- 23:04, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/10/ja (Created page with "また、白斑やハイリーハイリー病にも使用されている。")
- 23:04, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/9/ja (Created page with "==用途{{Anchor|Uses}}== 皮膚細胞の過剰なターンオーバーを抑える作用があるため、通常、乾癬や慢性ひび割れ唇などの重度の乾燥肌の治療薬として、開業医や皮膚科医から処方される。軟膏またはローションとして入手できる。")
- 23:03, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/8/ja (Created page with "==メカニズム{{Anchor|Mechanism}}== タカルシトールは、ケラチノサイト上のビタミンD受容体と相互作用することによって、表皮の過剰な細胞のターンオーバーを抑える。")
- 23:03, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/7/ja (Created page with "世界保健機関の必須医薬品リストに掲載されている。")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/6/ja (Created page with "'''タカルシトール'''（'''Tacalcitol'''）（1,24-dihydroxyvitamin D<sub>3</sub>）は合成ビタミンD<sub>3</sub>類似体である。タカルシトールは'''Curatoderm'''や'''Bonalfa'''などの名称で販売されている。")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/5/ja (Created page with "<!--Chemical data--> | C=27 | H=44 | O=3 | synonyms = (1α,24''R'')-1,24-Dihydroxyvitamin D<sub>3</sub> | smiles = O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3/b20-9+,21-10-/t18-,22-,23-,24+,25-,...")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/4/ja (Created page with "<!--Identifiers--> | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 57333-96-7 | ATC_prefix = D05 | ATC_suffix = AX04 | PubChem = 5283734 | IUPHAR_ligand = 2780 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | UNII_Ref = {{fdacite|changed|FDA}} | UNII = C2W72OJ5ZU | ChEBI = 32176 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 340361 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 4446823")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/3/ja (Created page with "<!--Pharmacokinetic data--> | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/2/ja (Created page with "<!--Clinical data--> | tradename = | Drugs.com = {{drugs.com|international|tacalcitol}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category = | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | legal_US = <!-- OTC...")
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/1/ja (Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 376121485 | IUPAC_name = (1''S'',3''R'',5''Z'',7''E'',24''R'')-9,10-secocholesta-5,7,10-triene-1,3,24-triol | image = Tacalcitol.svg")
- 23:02, 12 April 2024 Fire talk contribs created page Tacalcitol/ja (Created page with "タカルシトール") Tags: Mobile edit Mobile web edit
- 23:02, 12 April 2024 Fire talk contribs created page Translations:Tacalcitol/Page display title/ja (Created page with "タカルシトール")
- 23:02, 12 April 2024 Fire talk contribs marked Tacalcitol for translation
- 23:02, 12 April 2024 Fire talk contribs set the priority languages for translatable page Tacalcitol to Japanese
- 23:00, 12 April 2024 Fire talk contribs created page tacalcitol (Q22024) (wbeditentity-create:2|en: tacalcitol, chemical compound)
- 22:58, 12 April 2024 Fire talk contribs created page Tacalcitol (Created page with "<languages /> <translate> {{Short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 376121485 | IUPAC_name = (1''S'',3''R'',5''Z'',7''E'',24''R'')-9,10-secocholesta-5,7,10-triene-1,3,24-triol | image = Tacalcitol.svg <!--Clinical data--> | tradename = | Drugs.com = {{drugs.com|international|tacalcitol}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D /...")
- 22:55, 12 April 2024 Fire talk contribs created page Translations:Calcipotriol/25/ja (Created page with "カルシポトリオールの代謝物は親化合物より作用が弱い。")
